Open Beta
TREN
MetriLume
TREN

US marketsKMTS

SEC-sourced researchBeta

KMTS

KESTRA MEDICAL TECHNOLOGIES, LTD.

Company comparison ↗

Data passport

CIK
0001877184
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Oct 1, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: April 2024: 27,814,000.0000 USD; April 2025: 59,815,000.0000 USD59.8M USD0 USD0April 2024April 2025
KMTS · Exact amounts and source periods · USD
Period endRevenueFiling date
April 202427,814,000.0000Jul 17, 2025
April 202559,815,000.0000Jul 17, 2025

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
April 202559,815,000.0000-113,814,000.0000-77,608,000.0000295,744,000.000090,338,000.0000Jul 17, 2025
April 202427,814,000.0000-94,120,000.0000-72,235,000.000045,949,000.000078,216,000.0000Jul 17, 2025

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$59.82MApril 2025Jul 17, 202510-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$27.81MApril 2024Jul 17, 202510-K
Net incomeNetIncomeLoss-$113.81MApril 2025Jul 17, 202510-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$77.61MApril 2025Jul 17, 202510-K
Total assetsAssets$295.74MApril 2025Jul 17, 202510-K
Total liabilitiesLiabilities$90.34MApril 2025Jul 17, 202510-K

New filings

Explore methodology ↗